Name
SB249553
Alternate Names
SB 249553
SB-249553
Abbreviations
None
Category
Biologic therapy (BRM, immunotherapy)
Subcategory
Immunotherapy active
NSC Number
None
Primary Site
Histology
None
Remarks
Phase II Recombinant Therapeutic Vaccine. GlaxoSmithKline.
Coding
This drug should be coded